Canada markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.23-0.05 (-0.11%)
At close: 04:00PM EDT
44.23 0.00 (0.00%)
After hours: 05:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.29B
Enterprise Value 5.51B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)7.38
Price/Book (mrq)10.06
Enterprise Value/Revenue 6.49
Enterprise Value/EBITDA -1.94k

Trading Information

Stock Price History

Beta (5Y Monthly) 0.64
52-Week Change 336.96%
S&P500 52-Week Change 3-15.35%
52 Week High 348.82
52 Week Low 325.04
50-Day Moving Average 343.22
200-Day Moving Average 337.13

Share Statistics

Avg Vol (3 month) 3984.37k
Avg Vol (10 day) 31.29M
Shares Outstanding 5141.94M
Implied Shares Outstanding 6N/A
Float 8140.51M
% Held by Insiders 10.59%
% Held by Institutions 187.83%
Shares Short (Sept 14, 2022) 46.8M
Short Ratio (Sept 14, 2022) 47.75
Short % of Float (Sept 14, 2022) 45.67%
Short % of Shares Outstanding (Sept 14, 2022) 44.79%
Shares Short (prior month Aug 14, 2022) 46.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin -3.32%
Operating Margin (ttm)-0.41%

Management Effectiveness

Return on Assets (ttm)-0.09%
Return on Equity (ttm)-4.66%

Income Statement

Revenue (ttm)848.81M
Revenue Per Share (ttm)6.00
Quarterly Revenue Growth (yoy)6.40%
Gross Profit (ttm)164.57M
Net Income Avi to Common (ttm)-28.15M
Diluted EPS (ttm)-0.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.04B
Total Cash Per Share (mrq)14.36
Total Debt (mrq)1.25B
Total Debt/Equity (mrq)200.59
Current Ratio (mrq)8.18
Book Value Per Share (mrq)4.41

Cash Flow Statement

Operating Cash Flow (ttm)98.37M
Levered Free Cash Flow (ttm)166.66M